HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
4317studies shown
Showing 1,681-1,692 of 4,317
Drug study icon
RecruitingNCT07184619

Evenamide added to usual care for treatment-resistant schizophrenia

About this title

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Read the official source — NCT07184619
Official study title

A Phase III, 12-week, Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Determine the Efficacy, Safety, and Tolerability of a Dose of 15 mg Bid of Evenamide as add-on in Patients With Documented Treatment-resistant Schizophrenia, Which is Not Adequately Controlled by a Stable Therapeutic Dose of the Patient's Current Antipsychotic Medication(s)

Multiple locations, including Vijayawada
SchizophreniaMedication studyAges 18+
Countries
United States, Argentina, India, + 1 other
Sponsor
Newron Pharmaceuticals SPA
Other study type icon
RecruitingNCT07280416

Sleep problems during the first year after a cancer diagnosis

About this title

Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer

Read the official source — NCT07280416
Official study title

Evolution of Insomnia During the First Year in Patients Newly Diagnosed With Cancer: a Longitudinal Study and Analysis of Associated Factors.

In Le Puy-en-Velay
Anxiety, DepressionObservational studyAges 18–80
Countries
France
Sponsor
Centre Hospitalier Emile Roux
Device study icon
RecruitingNCT04197921

Feasibility of low-intensity ultrasound brain stimulation for substance use

About this title

Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)

Read the official source — NCT04197921
Official study title

A Feasibility Clinical Trial of Exablate for Low Intensity Focused Ultrasound Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Abuse Disorders (SUDs)

Multiple locations, including Baltimore
AddictionDevice studyAges 18–60
Countries
United States
Sponsor
InSightec
Behavioral study icon
RecruitingNCT06810180

Sleep, daily activity, and behavior in people with ADHD

About this title

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

Read the official source — NCT06810180
Official study title

Examination of the Dynamic Relationships of Sleep, Physical Activity, and Circadian Rhythmicity With Neurobehavioral Heterogeneity in ADHD

In Baltimore
ADHDBehavioural studyAges 8–12
Countries
United States
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Behavioral study icon
RecruitingNCT06394284

MDMA-assisted therapy or trauma-focused therapy for veterans with PTSD and moral injury

About this title

Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury

Read the official source — NCT06394284
Official study title

IISPT2: Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and MI

In Jerusalem
PTSDMedication study
Countries
Israel
Sponsor
Herzog Hospital
Behavioral study icon
RecruitingNCT06194851

Oxytocin or placebo added to couples therapy for veterans with PTSD

About this title

Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD

Read the official source — NCT06194851
Official study title

A Randomized Clinical Trial Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD

In San Diego
PTSDMedication studyAges 18+
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Other study type icon
RecruitingNCT06081426

Ketogenic diet and brain, metabolism and emotions during bipolarity

About this title

Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)

Read the official source — NCT06081426
Official study title

Elucidating Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD): a Multidisciplinary Mechanistic Study

In Pittsburgh
BipolarityInterventional studyAges 18–40
Countries
United States
Sponsor
University of Pittsburgh

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.